Cox J - Search Results

1

Risk Factors for Hepatitis C Virus Reinfection After Sustained Virologic Response in Patients Coinfected With HIV.

Young J, Rossi C, Gill J, Walmsley S, Cooper C, Cox J, Martel-Laferriere V, Conway B, Pick N, Vachon ML, Klein MB; Canadian Co-infection Cohort Investigators. Young J, et al. Among authors: cox j. Clin Infect Dis. 2017 May 1;64(9):1154-1162. doi: 10.1093/cid/cix126. Clin Infect Dis. 2017. PMID: 28199495 Free PMC article.

2

CTN-194 (PICCO): design of a trial of citalopram for the prevention of depression and its consequences in HIV-hepatitis C co-infected individuals initiating pegylated interferon/ribavirin therapy.

Klein MB, Cooper C, Brouillette MJ, Sheehan NL, Benkelfat C, Annable L, Weston F, Kraus D, Singer J; CTN194 Investigators. Klein MB, et al. Contemp Clin Trials. 2008 Jul;29(4):617-30. doi: 10.1016/j.cct.2008.01.001. Epub 2008 Jan 12. Contemp Clin Trials. 2008. PMID: 18262853 Clinical Trial.

3

Impact of hepatitis C viral replication on CD4+ T-lymphocyte progression in HIV-HCV coinfection before and after antiretroviral therapy.

Potter M, Odueyungbo A, Yang H, Saeed S, Klein MB; Canadian Co-infection Cohort Study Investigators. Potter M, et al. AIDS. 2010 Jul 31;24(12):1857-65. doi: 10.1097/QAD.0b013e32833adbb5. AIDS. 2010. PMID: 20479633

4

Transmission clustering drives the onward spread of the HIV epidemic among men who have sex with men in Quebec.

Brenner BG, Roger M, Stephens D, Moisi D, Hardy I, Weinberg J, Turgel R, Charest H, Koopman J, Wainberg MA; Montreal PHI Cohort Study Group. Brenner BG, et al. J Infect Dis. 2011 Oct 1;204(7):1115-9. doi: 10.1093/infdis/jir468. J Infect Dis. 2011. PMID: 21881127 Free PMC article.

5

HIV and hepatitis C virus coinfection in Canada: challenges and opportunities for reducing preventable morbidity and mortality.

Klein MB, Rollet KC, Saeed S, Cox J, Potter M, Cohen J, Conway B, Cooper C, Côté P, Gill J, Haase D, Haider S, Hull M, Moodie E, Montaner J, Pick N, Rachlis A, Rouleau D, Sandre R, Tyndall M, Walmsley S; Canadian HIV-HCV Cohort Investigators. Klein MB, et al. Among authors: cox j. HIV Med. 2013 Jan;14(1):10-20. doi: 10.1111/j.1468-1293.2012.01028.x. Epub 2012 May 28. HIV Med. 2013. PMID: 22639840 Free article.

6

Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study.

Eron JJ, Clotet B, Durant J, Katlama C, Kumar P, Lazzarin A, Poizot-Martin I, Richmond G, Soriano V, Ait-Khaled M, Fujiwara T, Huang J, Min S, Vavro C, Yeo J; VIKING Study Group. Eron JJ, et al. J Infect Dis. 2013 Mar 1;207(5):740-8. doi: 10.1093/infdis/jis750. Epub 2012 Dec 7. J Infect Dis. 2013. PMID: 23225901 Free PMC article. Clinical Trial.

7

Correlates of drug use cessation among participants in the Canadian HIV-HCV Co-infection Cohort.

Cox J, Maurais E, Hu L, Moodie EE, Law S, Bozinoff N, Potter M, Rollet K, Hull M, Tyndall M, Cooper C, Gill J, Saeed S, Klein MB; Canadian Co-infection Cohort (CTN 222). Cox J, et al. Drug Alcohol Depend. 2014 Apr 1;137:121-8. doi: 10.1016/j.drugalcdep.2014.01.014. Epub 2014 Jan 30. Drug Alcohol Depend. 2014. PMID: 24559606

8

HIV virological rebounds but not blips predict liver fibrosis progression in antiretroviral-treated HIV/hepatitis C virus-coinfected patients.

Cooper C, Rollet-Kurhajec KC, Young J, Vasquez C, Tyndall M, Gill J, Pick N, Walmsley S, Klein MB; Canadian Co-infection Cohort Study Investigators. Cooper C, et al. HIV Med. 2015 Jan;16(1):24-31. doi: 10.1111/hiv.12168. Epub 2014 May 18. HIV Med. 2015. PMID: 24837567 Free PMC article.

9

Variation between Canadian centres in the uptake of treatment for hepatitis C by patients coinfected with HIV: a prospective cohort study.

Young J, Potter M, Cox J, Cooper C, Gill J, Hull M, Walmsley S, Klein MB. Young J, et al. Among authors: cox j. CMAJ Open. 2013 Sep 24;1(3):E106-14. doi: 10.9778/cmajo.20130009. eCollection 2013 Sep. CMAJ Open. 2013. PMID: 25077109 Free PMC article.

10

Favourable IFNL3 genotypes are associated with spontaneous clearance and are differentially distributed in Aboriginals in Canadian HIV-hepatitis C co-infected individuals.

Moqueet N, Infante-Rivard C, Platt RW, Young J, Cooper C, Hull M, Walmsley S, Klein MB; Canadian Co-Infection Study Investigators. Moqueet N, et al. Int J Mol Sci. 2015 Mar 20;16(3):6496-512. doi: 10.3390/ijms16036496. Int J Mol Sci. 2015. PMID: 25803108 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,698 results

Search Page